(3R,4R,5S)-4-Acetamido-5-amino-N-hydroxy-3-(pentan-3-yloxy)cyclohex-1-enecarboxamide

ID: ALA3342331

Chembl Id: CHEMBL3342331

PubChem CID: 118716383

Max Phase: Preclinical

Molecular Formula: C14H25N3O4

Molecular Weight: 299.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)NO)C[C@H](N)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C14H25N3O4/c1-4-10(5-2)21-12-7-9(14(19)17-20)6-11(15)13(12)16-8(3)18/h7,10-13,20H,4-6,15H2,1-3H3,(H,16,18)(H,17,19)/t11-,12+,13+/m0/s1

Standard InChI Key:  KJHUVPWNXPXUMQ-YNEHKIRRSA-N

Alternative Forms

  1. Parent:

    ALA3342331

    ---

Associated Targets(non-human)

NA Neuraminidase (159 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (2284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 299.37Molecular Weight (Monoisotopic): 299.1845AlogP: 0.23#Rotatable Bonds: 6
Polar Surface Area: 113.68Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 9.64CX Basic pKa: 8.90CX LogP: -0.87CX LogD: -2.06
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.41Np Likeness Score: 0.96

References

1. Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W..  (2014)  Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.,  57  (20): [PMID:25255388] [10.1021/jm500892k]
2. Hong BT, Chen CL, Fang JM, Tsai KC, Wang SY, Huang WI, Cheng YS, Wong CH..  (2014)  Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.,  22  (23): [PMID:25456388] [10.1016/j.bmc.2014.10.005]

Source